W
Woo Joo Kim
Researcher at Korea University
Publications - 286
Citations - 6890
Woo Joo Kim is an academic researcher from Korea University. The author has contributed to research in topics: Vaccination & Influenza vaccine. The author has an hindex of 35, co-authored 257 publications receiving 5352 citations. Previous affiliations of Woo Joo Kim include Yonsei University & Korea University Medical Center.
Papers
More filters
Clinical Features and Prognosisof Community-acquired Pneumonia in the Elderly Patients
Cheol Woong Yu,Cheong Won Park,Byung Yoen Hwang,Joon Young Song,Ok Park,Jang Wook Sohn,Hee Jin Cheong,Woo Joo Kim,Min Ja Kim,Seung Chul Park +9 more
Journal ArticleDOI
Immunogenicity and safety of a cell culture-derived inactivated quadrivalent influenza vaccine (NBP607-QIV): A randomized, double-blind, multi-center, phase III clinical trial in adults and elderly subjects
Won Suk Choi,Ji Yun Noh,Joon Young Song,Hee Jin Cheong,Seong Heon Wie,Jin Soo Lee,Jacob Lee,Shin Woo Kim,Hye Won Jeong,Sook-In Jung,Yeon Sook Kim,Heung Jeong Woo,Kyung Ho Kim,Hun Kim,Woo Joo Kim +14 more
TL;DR: NBP607-QIV is a safe, well-tolerated and immunogenic influenza vaccine in Korean adults and elderly subjects and demonstrates non-inferiority against shared strains and superiority against alternate-lineage B strains.
Journal ArticleDOI
Hospital-based influenza morbidity and mortality surveillance system for influenza-like illnesses: a comparison with national influenza surveillance systems.
Yu Bin Seo,Joon Young Song,Hee Jin Cheong,Young Duck Cho,Seong Heon Wie,Hye Won Jeong,Woo Joo Kim +6 more
TL;DR: Rapid antigen‐test‐based HIMM surveillance would predict the start of influenza epidemic earlier than pre‐existing influenza‐like‐illness‐based surveillance, and strong correlations were found.
Journal ArticleDOI
Immunogenicity and safety of a cell culture-derived inactivated trivalent influenza vaccine (NBP607): A randomized, double-blind, multi-center, phase 3 clinical trial.
Joon Young Song,Hee Jin Cheong,Jacob Lee,Heung Jeong Woo,Seong Heon Wie,Jin Soo Lee,Shin Woo Kim,Ji Yun Noh,Won Suk Choi,Hun Kim,Kyung Ho Kim,Woo Joo Kim +11 more
TL;DR: NBP607, a novel CCIV, showed excellent immunogenicity that lasted ≥6 months after vaccination and had tolerable safety profiles, and was more immunogenic against influenza B compared to the control, an egg-based subunit vaccine.
Journal ArticleDOI
Molecular genetic characteristics of influenza A virus clinically isolated during 2011-2016 influenza seasons in Korea.
Han Sol Lee,Ji Yun Noh,Joon Young Song,Hee Jin Cheong,Won Suk Choi,Hye Won Jeong,Seong Heon Wie,Woo Joo Kim +7 more
TL;DR: The influenza virus is reportedly associated with 3‐5 million cases of severe illness and 250 000‐500 000 deaths annually worldwide.